
CME Group Inc.: stock overview
Price
$317.97
November 13, 2026Market cap $114B
What Ploutos Investor adds for CME
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
In short
CME had revenue of $7.0B over the last 12 months and net income of $4.4B, a net margin of 63.7%. Revenue grew by 5.9% a year on average over the last 5 years. At $317.97 the shares trade at a P/E of 25.9, against a median of 24.0 over the last 5 fiscal years. It holds more cash than debt, by $154B. It pays a dividend yielding 1.62%.
From its SEC filings (latest fiscal year to December 31, 2025) and the price of November 13, 2026.
Its SEC filings- Market cap
- $114B
- 360M shares
- P/E
- 25.9
- Today25.9Median24.0
- Revenue, 12 months
- $7.0B
- +5.9% a year over 5 years
- Net margin
- 63.7%
- 2025: 62.5%, above 97% of its industry
Worth knowing
What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.
3 fiscal years in figures
Each fiscal year's figures as the company filed them, and the share price at its end.
+8.1% a year over 2 years
Fiscal years in figures
CME's revenue, profit, cash flow and dividend with each year-end price, from 2009 to 2022, 14 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
Key figures
The company's current figures in five groups. Each term is explained behind its ⓘ.
Valuation
- Market cap 3-year median: $83.5B
- $114B
- Enterprise value
- –
- P/E 3-year median: 24.0
- 25.9
- EV / EBIT
- –
- EV / Revenue
- –
- P/B 3-year median: 3.2
- 4.3
- FCF yield 3-year median: 4.3%
- 3.8%
- Earnings yield 3-year median: 4.2%
- 3.9%
Profitability
- Operating margin
- 65.7%
- Net margin 3-year median: 57.8%
- 63.7%
- ROIC
- 12.8%
- ROIC, 5-year average
- 9.9%
- ROE
- 16.3%
Growth
- Revenue, yearly change
- +6.4%
- EPS, yearly change
- +15.4%
- FCF, yearly change
- +16.6%
- Revenue, average a year
- +5.9%
- EPS, average a year
- +13.7%
The yearly change compares FY2025 with FY2024.
Balance sheet
- Cash
- $158B
- Total debt
- $3.9B
- Of which operating leases
- $384M
- Net cash
- $154B
- Net debt / EBITDA
- -32.9x
- Interest cover
- 26.3x
- Current ratio
- 1.02
Balance sheet of September 30, 2026.
Returns to shareholders
- Dividend yield 3-year median: 4.5%
- 1.62%
- Buybacks
- –
- Total returned
- 1.62%
- Shares, yearly change
- +0.1%
Against its industry
Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 62).
Operating margin
64.9%
Above 97% of the 46 companies in its industry, and 99% of all.
Net margin
62.5%
Above 97% of the 82 companies in its industry, and 99% of all.
ROE
14.2%
Above 48% of the 74 companies in its industry, and 74% of all.
ROA
2.1%
Above 38% of the 78 companies in its industry, and 55% of all.
Revenue growth
6.4%
Above 32% of the 80 companies in its industry, and 50% of all.
From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.
The company at the SEC
How it is registered and when its fiscal year ends.
- Name at the SEC
- CME GROUP INC.
- CIK
- 1156375
- Exchange
- NASDAQ
- Industry (SIC)
- 6200 · Security & Commodity Brokers, Dealers, Exchanges & Services
- Fiscal year ends
- December 31
- Latest annual report
- December 31, 2025
- Reporting currency
- USD
- Shares
- 360M
Other companies: Financial services
The largest companies of the same sector, each with its own page.
- BRK.ABerkshire Hathaway+0,00%Compare with CME
- JPMJP Morgan Chase & Co.+0,00%Compare with CME
- VVisa+0,00%Compare with CME
- MAMastercard+0,00%Compare with CME
- BACBank of America+0,00%Compare with CME
- GSGoldman Sachs+0,00%Compare with CME
- WFCWells Fargo & Company+0,00%Compare with CME
- MSMorgan Stanley+0,00%Compare with CME
The full analysis
What do CME's filings show?
These are CME's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
What is CME's market cap?
CME Group Inc.'s market cap is $114B, at a price of $317.97 on November 13, 2026 and 360M shares.
What is CME's P/E?
CME's P/E is 25.9, on earnings per share of $12.19 over the last 12 months. The median over the last 5 fiscal years was 24.0.
How much revenue does CME have?
CME had revenue of $7.0B over the last 12 months. Over the last 5 years it changed by +5.9% a year on average.
Does CME pay a dividend?
Yes. CME paid $5.15 per share over the last 12 months, a yield of 1.62% at today's price. All the figures are in the Dividend section.
Where do the figures come from?
From CME Group Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.